LAUSR

Glioma is the most common type of primary intracranial tumor. Dysregulation of circular RNAs (circRNAs) plays a critical role in multiple solid tumors. However, the expression profiles of circRNAs and their functions in glioma have been rarely studied. The current work aims to investigate the clinical significance of a novel circRNA, circ‐POSTN, in glioma and explore its biological functions and mechanisms in the progression of glioma. We found that circ‐POSTN was highly expressed in glioma tissue samples and cells. High circ‐POSTN expression was significantly linked to larger tumor size, higher World Health Organization grades, and shorter overall survival. Furthermore, silencing of circ‐POSTN in glioma cells could decrease cell growth, migratory and invasive potential, and induce cell apoptosis in LN229 cells. On the contrary, ectopically expressed circ‐POSTN induced the opposite effects in the U251 cell line. By bioinformatic prediction and luciferase reporter assay, we identified that miR‐1205 could be sponged by circ‐POSTN. Further rescue assays demonstrated that the oncogenic functions of circ‐POSTN are partly attributed to its regulation of miR‐1205 in glioma cells. Taken together, our data suggest that circ‐POSTN plays an oncogenic role in glioma progression and may serve as a novel therapeutic target in this deadly disease.